Skip to main content

Table 3 Associations between sCD36 levels and a variety of clinical and biochemical parameters

From: Impact of the interaction between the polymorphisms and hypermethylation of the CD36 gene on a new biomarker of type 2 diabetes mellitus: circulating soluble CD36 (sCD36) in Senegalese females

sCD36 (pg/ml)

Control n = 50

Type 2 diabetes mellitus n = 50

Coefficient

p value

Coefficient

p value

Body mass index (kg/m2)

r =  − 0.20

0.15

r = 0.06

0.67

Waist–hip ratio

r =  − 0.22

0.12

r = 0.13

0.35

Glycated hemoglobin (%)

r =  − 0.20

0.16

r = 0.13

0.36

HOMA-IR

r =  − 0.05

0.74

r =  − 0.14

0.35

Total cholesterol (g/l)

r =  − 0.24

0.09

r = 0.28

0.04*

HDL cholesterol (g/l)

r =  − 0.52

0.0001***

r =  − 0.07

0.64

LDL cholesterol (g/l)

r = 0.14

0.34

r = 0.24

0.09

Triglycerides (g/l)

r =  − 0.36

0.01**

r = 0.09

0.54

  1. HOMA-IR Homeostasis Model Assessment-Insulin Resistance, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.0001